In this Article. Breast cancer can come back as a local recurrence (meaning in the treated breast or near the mastectomy scar) or somewhere else in the body. Some of the most common sites of recurrence outside the breast are the lymph nodes, bones, liver, lungs, and brain.
ER-positive breast cancer is the most common type of breast cancer diagnosed today. Find out what ER-positive breast cancer means and learn about treatment options as well as long-term prognosis.
View on the News. For the entire patient group, breast cancer recurrence reached a peak at years 1-2 (15.2%), and decreased consistently through year 10 (5-10 years, 4.5%), then remained stable (10-15 years, 2.2%; 15-20, 1.5%; 20-25, 0.7%). Cumulative incidence of distant recurrence for the ER-positive group occurred less frequently than for
Key Point 3. If breast cancer becomes a chronic condition whose symptoms must be constantly monitored and treated as needed, the emotional and psychological symptoms must be included. Breast cancer recurrence can create fear, anxiety, stress, and depression. It can lead to a sense of uncertainty and lack of control.
The Breast Cancer Index (BCI) Risk of Recurrence & Extended Endocrine Benefit Test is intended for use in patients diagnosed with estrogen receptor-positive (ER+), lymph node-negative (LN-) or lymph node positive (LN+; with 1-3 positive nodes) early-stage, invasive breast cancer, who are distant recurrence-free.
Any views expressed above are the author’s own and do not necessarily reflect the views of WebMD or Medscape. Cite this article: Late Recurrence in ER- Positive Breast Cancer: Banking on
Breast Cancer Recurrence Risk Lingers Years After Treatment Ends. Steady rates of recurrence in women with estrogen receptor-positive disease could influence decisions about long-term therapy. Even 20 years after a diagnosis, women with a type of breast cancer fueled by estrogen still face a substantial risk of cancer returning or spreading,
In estrogen-receptor (ER)–positive early-stage breast cancer, 5 years of adjuvant endocrine therapy substantially reduces the risks of locoregional and distant recurrence, contralateral breast
Cited by: 72
Breast cancer can recur at the original site (called local recurrence). It can also return and spread to other parts of the body (called metastasis or distant recurrence). Local recurrence is usually found on a mammogram, during a physical exam by a health care provider or when you notice a change.
Generally, these factors relate to the patient’s age, the cancer’s stage at diagnosis, hormone receptor status, genetic information, and lymph node involvement. Breast cancer survivors with a higher risk of late recurrence are: Survivors with the following receptor statuses. Estrogen …
Sep 27, 2018 · Forum: HER2+ (Positive) Breast Cancer — Testing, treatment, side effects, and more. In the BCIRG 006 drug trial, they reported the recurrence rate for the node negative participants. after 4 years, In the TCH arm, 7% had recurrences. Most of the recurrences happened between 1 year and 3 years after treatment.
|Breast Cancer Topic: Recurrence risk for HER2 + with pCR?||Jan 20, 2019|
|Breast Cancer Topic: HER2 positive survival and recurrence||Jan 10, 2019|
|Forum: HER2+ (Positive) Breast Cancer||Oct 30, 2018|
|Topic: When do most recurrences for HER2 happen||Oct 28, 2018|